VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 107 filers reported holding VAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $848 | +14.9% | 16,641 | +12.6% | 0.09% | -31.3% |
| Q2 2023 | $738 | +16.2% | 14,778 | -12.8% | 0.13% | +54.0% |
| Q1 2023 | $635 | +80.9% | 16,955 | +131.7% | 0.09% | +64.2% |
| Q4 2022 | $351 | -99.9% | 7,318 | -40.3% | 0.05% | +17.8% |
| Q3 2022 | $294,000 | +13.5% | 12,258 | +2.9% | 0.04% | -2.2% |
| Q2 2022 | $259,000 | -65.4% | 11,910 | -57.8% | 0.05% | -49.5% |
| Q4 2020 | $749,000 | – | 28,191 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
| RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
| Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
| Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
| Penn Mutual Asset Management, LLC | 22,227 | $439,000 | 0.50% |